JAK3 and cutaneous squamous cell carcinoma: None of these mutations are classified as being clinically pathogenic by the dbSNP database, and only the JAK3 mutation is present in the COSMIC database (in leukemias, glioblastomas and cutaneous squamous cell carcinoma) which is an activating mutation23.